COMPARISON OF DIFFERENT REMISSION INDICES IN PATIENTS WITH PSORIATIC ARTHRITIS: A POST HOC ANALYSIS OF DATA FROM PHASE 3 TOFACITINIB STUDIES

被引：0
|
作者：
Schneeberger, E. [1 ]
Citera, G. [1 ]
Nash, P. [2 ]
Smolen, J. S. [3 ]
Mease, P. J. [4 ,5 ]
Soriano, E. [6 ]
Helling, C. [7 ]
Szumski, A. E. [8 ]
Mundayat, R. [9 ]
Graham, D. [10 ]
Ponce de Leon, D. [11 ]
机构：
[1] Inst Rehabil Psicofis, Buenos Aires, DF, Argentina
[2] Griffith Univ, Brisbane, Qld, Australia
[3] Med Univ Vienna, Vienna, Austria
[4] Swedish Med Ctr, Seattle, WA USA
[5] Univ Washington, Seattle, WA 98195 USA
[6] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina
[7] Pfizer Inc, Buenos Aires, DF, Argentina
[8] Pfizer Inc, Collegeville, PA USA
[9] Pfizer Inc, New York, NY USA
[10] Pfizer Inc, Groton, CT 06340 USA
[11] Pfizer Inc, Lima, Peru
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.948
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0831
引用
收藏
页码：1716 / 1717
页数：2
相关论文
共 50 条
  • [21] Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 Studies
    Nash, Peter
    Coates, Laura C.
    Fleischmann, Roy
    Papp, Kim A.
    Jesus Gomez-Reino, Juan
    Kanik, Keith S.
    Wang, Cunshan
    Wu, Joseph
    Menon, Sujatha
    Hendrikx, Thijs
    Ports, William C.
    RHEUMATOLOGY AND THERAPY, 2018, 5 (02) : 567 - 582
  • [22] Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 Studies
    Peter Nash
    Laura C. Coates
    Roy Fleischmann
    Kim A. Papp
    Juan Jesus Gomez-Reino
    Keith S. Kanik
    Cunshan Wang
    Joseph Wu
    Sujatha Menon
    Thijs Hendrikx
    William C. Ports
    Rheumatology and Therapy, 2018, 5 : 567 - 582
  • [23] Secukinumab in the Treatment of Dactylitis in Patients with Psoriatic Arthritis: Post Hoc Analysis Results from a Randomized Phase 3 Trial
    Kirkham, Bruce
    Nash, Peter
    Navarra, Sandra
    Quebe-Fehling, Erhard
    Gaillez, Corine
    Sastre, Carlos
    Mease, Philip
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [24] Relationships Between Psoriatic Arthritis Disease Activity Score and Patient-Reported Outcomes in Patients with Psoriatic Arthritis: Post Hoc Analysis of Two Phase 3 Studies
    Coates, Laura
    Bushmakin, Andrew
    FitzGerald, Oliver
    Gladman, Dafna
    Fallon, Lara
    Cappelleri, Joseph
    Hsu, Ming-Ann
    Helliwell, Philip
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [25] Efficacy and safety of tofacitinib by background methotrexate dose in psoriatic arthritis: post hoc exploratory analysis from two phase III trials
    Kivitz, Alan J.
    FitzGerald, Oliver
    Nash, Peter
    Pang, Shirley
    Azevedo, Valderilio F.
    Wang, Cunshan
    Takiya, Liza
    CLINICAL RHEUMATOLOGY, 2022, 41 (02) : 499 - 511
  • [26] Efficacy and safety of tofacitinib by background methotrexate dose in psoriatic arthritis: post hoc exploratory analysis from two phase III trials
    Alan J. Kivitz
    Oliver FitzGerald
    Peter Nash
    Shirley Pang
    Valderilio F. Azevedo
    Cunshan Wang
    Liza Takiya
    Clinical Rheumatology, 2022, 41 : 499 - 511
  • [27] PAIN REDUCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TOFACITINIB MONOTHERAPY WITH OR WITHOUT PAIN MEDICATION: A POST HOC ANALYSIS OF POOLED DATA FROM PHASE 2, PHASE 3 AND PHASE 3B/4 STUDIES
    Taylor, Peter C.
    van de Laar, Mart
    Curtis, Jeffrey R.
    Azevedo, Valderilio F.
    Luis Rivas, Jose
    Dahl, Palle
    Wang, Lisy
    Iikuni, Noriko
    Shi, Harry
    Woolcott, John
    Benkhalifa, Salim
    Gomez-Reino, Juan Jose
    Dougados, Maxime
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1687 - 1688
  • [28] The impact of tofacitinib on fatigue, sleep, and health-related quality of life in patients with rheumatoid arthritis: a post hoc analysis of data from Phase 3 trials
    Susan J. Bartlett
    Clifton O. Bingham
    Ronald van Vollenhoven
    Christopher Murray
    David Gruben
    David A. Gold
    David Cella
    Arthritis Research & Therapy, 24
  • [29] The impact of tofacitinib on fatigue, sleep, and health-related quality of life in patients with rheumatoid arthritis: a post hoc analysis of data from Phase 3 trials
    Bartlett, Susan J.
    Bingham, Clifton O.
    van Vollenhoven, Ronald
    Murray, Christopher
    Gruben, David
    Gold, David A.
    Cella, David
    ARTHRITIS RESEARCH & THERAPY, 2022, 24 (01)
  • [30] Sex differences in the efficacy, safety and persistence of patients with psoriatic arthritis treated with tofacitinib: a post-hoc analysis of phase 3 trials and long-term extension
    Eder, Lihi
    Gladman, Dafna D.
    Mease, Philip
    Pollock, Remy A.
    Luna, Rayana
    Aydin, Sibel Z.
    Ogdie, Alexis
    Polachek, Ari
    Gruben, David
    Cadatal, Mary Jane
    Kinch, Cassandra
    Strand, Vibeke
    RMD OPEN, 2023, 9 (01):
12345